Insights

Strategic Growth Cannara operates two mega facilities in Quebec with substantial cultivation capacity and a focus on premium-grade products. This presents cross-sell opportunities for processing partnerships, packaging innovations, and branded product lines to expand distribution within Quebec and nationally.

Financing Stability Recent credit facility extension with Bank of Montreal and loan restructuring indicate strengthened liquidity and longer investment runway. This supports collaborations on capital-intensive projects, equipment upgrades, and expansion of manufacturing capabilities.

Market Expansion Venturing into cannabis vaping with Tribal devices and a focus on competitive pricing suggests opportunities in device partnerships, compliance-friendly hardware, and co-branded product launches to capture share in Quebec and broader markets.

Strategic Leadership Addition of independent directors and participation in industry conferences signals openness to strategic partnerships and advisory relationships. Leverage these channels to propose joint ventures, research collaborations, and distribution agreements.

Data and Outreach Adoption of digital tools and engagement platforms (Power BI, Sprout Social, WordPress) indicates a data-driven market approach. Propose analytics-enabled marketing services, CRM integration, and digital enablement for retailer education and consumer targeting.

Similar companies to Cannara Biotech Inc.

Cannara Biotech Inc. Tech Stack

Cannara Biotech Inc. uses 8 technology products and services including Power BI, Open Graph, RSS, and more. Explore Cannara Biotech Inc.'s tech stack below.

  • Power BI
    Business Intelligence
  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • SAP
    Customer Relationship Management
  • MySQL
    Database
  • Mailchimp
    Email
  • Google Tag Manager
    Tag Management
  • GoDaddy
    Web Hosting

Media & News

Cannara Biotech Inc.'s Email Address Formats

Cannara Biotech Inc. uses at least 1 format(s):
Cannara Biotech Inc. Email FormatsExamplePercentage
First.Last@cannara.caJohn.Doe@cannara.ca
84%
First@cannara.caJohn@cannara.ca
13%
Last@cannara.caDoe@cannara.ca
2%
F.Last@cannara.caJ.Doe@cannara.ca
1%

Frequently Asked Questions

What is Cannara Biotech Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cannara Biotech Inc.'s official website is cannara.ca and has social profiles on LinkedIn.

What is Cannara Biotech Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Cannara Biotech Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cannara Biotech Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Cannara Biotech Inc. has approximately 160 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: N. S.Chief Technology Officer: A. K.Vice President Supply Chain: A. A.. Explore Cannara Biotech Inc.'s employee directory with LeadIQ.

What industry does Cannara Biotech Inc. belong to?

Minus sign iconPlus sign icon
Cannara Biotech Inc. operates in the Biotechnology Research industry.

What technology does Cannara Biotech Inc. use?

Minus sign iconPlus sign icon
Cannara Biotech Inc.'s tech stack includes Power BIOpen GraphRSSSAPMySQLMailchimpGoogle Tag ManagerGoDaddy.

What is Cannara Biotech Inc.'s email format?

Minus sign iconPlus sign icon
Cannara Biotech Inc.'s email format typically follows the pattern of First.Last@cannara.ca. Find more Cannara Biotech Inc. email formats with LeadIQ.

How much funding has Cannara Biotech Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Cannara Biotech Inc. has raised $119M in funding. The last funding round occurred on Feb 04, 2026.

When was Cannara Biotech Inc. founded?

Minus sign iconPlus sign icon
Cannara Biotech Inc. was founded in 2018.
Cannara Biotech Inc. logo

Cannara Biotech Inc.

Biotechnology ResearchQuebec, Canada51-200 Employees

Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis and derivative products serving Quebec and the broader Canadian market. The company focuses on delivering high-quality products with ongoing rotation of rare genetics and aims to price them competitively, along with transparent operations. It operates two large facilities in Quebec, spanning more than 1.65 million square feet, with an annual cultivation capacity of up to 125,000 kilograms, and is based in Saint-Laurent, Quebec. Cannara targets the Quebec and Canadian cannabis sectors, supplying retailers and consumers with premium offerings and prioritizing responsiveness to community needs. In 2025, the company expanded into the cannabis vaping market in Quebec with five branded devices.

Section iconCompany Overview

Website
cannara.ca
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $119M

    Cannara Biotech Inc. has raised a total of $119M of funding over 9 rounds. Their latest funding round was raised on Feb 04, 2026as a post_ipo_equity.

  • $10M$25M

    Cannara Biotech Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $119M

    Cannara Biotech Inc. has raised a total of $119M of funding over 9 rounds. Their latest funding round was raised on Feb 04, 2026as a post_ipo_equity.

  • $10M$25M

    Cannara Biotech Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.